Sk Innovation Co., Ltd.

Korea Research Institute of Bioscience and Biotechnology

Hyundai Motor Company

Kia Motors Corporation

Korea Research Institute of Chemical Technology

Lg Chem, Ltd

Lotte Chemical Corporation

The Industry & Academic Cooperation in Chungnam National University

Farmhannong Co., Ltd.

Ubix Therapeutics, Inc.

Kia Corporation

Hyun Jin Kim

Ji Seok Lee

Gil Jae You

Mi Jin Kim

Byung Kook Nam

Hyun Soo Kim

Ho Jun Kim

Jung Hoon Sohn

Kwang Mook Lim

Hak Soo Kim

Dae Sik Kim

Jong Hyun Kim

In Soo Han

Jee Hee Suh

Kyeong Hoon Jang

Sung Yun Cho

Young Kwan Ko

Yee Sook Cho

Jong Yeon Hwang

Jae Du Ha

Hanki Lee

Dong Wan Koo

Mi Young Son

Chi Hoon Park

Bong Hyun Sung

Chul Ho Kim

Seul Yi

Boo Youn An

Ill Young Lee

Gyu Hwan Yon

Nack Jeong Kim

Pil Ho Kim

So-Young Lee

Dong Joo Lim

Song Hee Lee

Jung Hoon Bae

Seung Kyu Yoon

Jae Deok Kim

Mi Sook Hong

Ah Reum Kim

Ji Youn Park

Je Ho Ryu

Ho Hyun Lee

Jung Min Ahn

Jae Cheol Ryou

You Jin Park

Junhyuk Choi

Jisoo Lim

Soon Ho Park

Hyeung Shin Lee

Hyeong Shin Lee

Eun Ae Kim

Hee Nam Lim

Seungae Oh

Ji Hun Seomoon

Yun Kyoung Hwang

Byung Hoon Ahn

Ye Seul Lim

Hee Jung Moon

Beom Seon Suh

Sun Mi Yoo

Han Wool Kim

Chan Yong Park

Sungjun Park

Hye Ji Han

Jung Sub Choi

Joo Hyun Lee

The present invention relates to a novel nicotinamide compound, a method for preparing the same, and a herbicide comprising the compound. The compound of the present invention is useful as a herbicide for foliar treatment or soil treatment because it has high safety for wheat or corn and has excellent herbicidal activity against grassy weeds, sedge weeds or broadleaf weeds.

Nicotinamide compound and herbicidal composition comprising compound

The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof

Provided is a security communication method in a NFV environment and a system thereof. A security communication method in the NFV environment according to an exemplary embodiment of the present invention is a security communication method between virtualized network functions (VNF) in a network function virtualization (NFV) environment including: performing authentication between a first VNF and a second VNF by an element manager using a hash chain; generating secret keys based on its own hash chains by the first VNF and the second VNF which are authenticated; and performing the communication by the first VNF and the second VNF using its own secret keys.

Security communication method in NFV environment and system thereof

Provided is a battery pack, and more particularly, a battery pack capable of preventing degradation of performance at a low temperature by allowing a portion of air exhausted through an exhaust port to be introduced into an inhalation port to optimize a temperature of external air introduced into a cell module.

Battery pack

The present invention relates to a battery module and cell configuration recognition system for ID assignment, and more specifically, to a battery module and cell configuration recognition system for ID assignment that recognizes the number of battery cells and battery modules connected in series in order to assign an ID to a BMS and a battery cell of each of the battery modules.

Battery module and cell configuration recognition system for ID assignment

According to an aspect of the present disclosure, a polyolefine resin composition includes 1 to 20 parts by weight of one polyolefine resin having a first melt index; 1 to 20 parts by weight of another polyolefine resin having a second melt index different from the first melt index; 60 to 85 parts by weight of an inorganic filler; and 5 to 20 parts by weight of a fluorine-acrylic copolymer-based compound.

Polyolefine resin composition, polyolefine master batch, method of manufacturing polyolefine master batch, and article formed of the same

A battery module assembly according to one embodiment of the present invention includes: a heat pipe having a battery module in which a plurality of battery cells are stacked in one direction, a coupling part which is in contact with and coupled to the side surface part of the battery module, and a cooling part which extends from the coupling part so as to project away from the battery module; and a cooling plate, one surface of which is in contact with and coupled to the cooling part of the heat pipe. A cooling passage may be formed on the other surface of the cooling plate. According to the present invention, heat generated from the battery module including the battery cell can be cooled effectively.

Battery module assembly

A polyolefin composite composition is used in an automotive air duct. The polyolefin composite composition is useful as an automotive air duct component material due to excellent mechanical property, heat resistance, and foaming property as a composition in which a polyethylene resin and a long chain branched polypropylene resin having low crystallization of 45% or less are included as a base resin.

Polyolefin composite composition for automotive airduct

The present invention relates to beta-glucosidase that is mutated to have enhanced activity, and a method for producing bioethanol using the same. More particularly, the present invention relates to a polynucleotide encoding beta-glucosidase that is mutated to have enhanced activity, beta-glucosidase expressed from the polynucleotide, an expression vector including the polynucleotide, a transformant that is transformed with the expression vector, a method for producing the mutated beta-glucosidase using the transformant, and a method for producing bioethanol using the transformant. The mutant beta-glucosidase of the present invention increases production of glucose much more than the conventional beta-glucosidase, and thus it can be widely used for economic production of bioethanol.

Mutant beta-glucosidases having enhanced activity and a method for producing bioethanol using the same

Provided are a battery module and a method for manufacturing the same. The battery module includes: a plurality of battery cells spaced apart from each other by a predetermined interval and stacked in parallel with each other; a plurality of heat exchange members integrally formed by connecting parts connecting between two partition walls neighboring to each other among partition walls each slid between the battery cells, respectively; and a filler applied onto the heat exchange members.

Battery module and method for manufacturing the same

The present invention relates to a large-scale propagation and maintenance method of embryoid bodies generated from stem cells. More particularly, the present invention relates to a large-scale propagation and maintenance method of embryoid bodies retaining their intrinsic characteristics for a long period of time, comprising the step of continuously subculturing embryoid bodies that are primarily produced from embryonic stem cells or from induced pluripotent stem cells. According to the method of the present invention, after preparation of embryoid bodies from a limited number of stem cells, large-scale production and maintenance of embryoid bodies can be realized by a simple mechanical subculturing method without the continuous supply of stem cells.

Large-scale propagation and maintenance method of embryoid bodies generated from stem cells

The present invention relates to a method for producing hEGF (human epidermal growth factor) which has the same activity as the wild form, in high concentration and with a high degree of purity. More specifically, the invention relates to an hEGF expression vector comprising a nucleic acid sequence coding for the polypeptide of sequence number 14; a host cell in which the expression vector has been genetically transformed; and a method for producing hEGF, comprising a step in which the expression vector is created and is genetically transformed in yeast from which the KEX1 gene is lacking. Using the method of the present invention, it is possible to produce a large volume of human derived EGF which has the same size and activity as human derived EGF, and this EGF can be used in various ways such as in medicine and cosmetics.

Method for producing human epidermal growth factor in large volume from yeast

Growing community of inventors

Daejeon, South Korea

Hyun Jin Kim